Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan · Delayed Price · Currency is JPY 1,874.00
-14.50 (-0.77%)
Jun 19, 2026, 3:30 PM JST
Santen Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 18, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 607,490 | 574,345 | 484,047 | 559,190 | 424,342 | 490,898 | |
Market Cap Growth | 13.28% | 18.66% | -13.44% | 31.78% | -13.56% | -19.37% |
Enterprise Value | 525,643 | 511,855 | 405,379 | 476,424 | 362,459 | 422,435 |
Last Close Price | 1888.50 | 1785.50 | 1386.62 | 1469.04 | 1056.18 | 1112.09 |
PE Ratio | 16.59 | 15.37 | 13.35 | 21.00 | - | 18.04 |
Forward PE | 15.81 | 16.06 | 14.12 | 17.09 | 25.03 | 16.26 |
PS Ratio | 2.08 | 1.97 | 1.61 | 1.85 | 1.52 | 1.84 |
PB Ratio | 2.05 | 1.94 | 1.70 | 1.83 | 1.45 | 1.46 |
P/TBV Ratio | 2.70 | 2.55 | 2.30 | 2.52 | 2.15 | 2.37 |
P/FCF Ratio | 16.57 | 15.67 | 8.92 | 8.83 | 21.36 | 17.11 |
P/OCF Ratio | 13.97 | 13.20 | 7.95 | 7.70 | 11.42 | 10.66 |
PEG Ratio | 3.43 | 2.79 | 2.79 | 2.79 | 2.79 | 2.79 |
EV/Sales Ratio | 1.80 | 1.76 | 1.35 | 1.58 | 1.30 | 1.59 |
EV/EBITDA Ratio | 7.95 | 7.74 | 6.12 | 6.77 | 6.90 | 7.98 |
EV/EBIT Ratio | 11.00 | 10.71 | 8.39 | 9.13 | 10.27 | 11.78 |
EV/FCF Ratio | 14.34 | 13.96 | 7.47 | 7.52 | 18.24 | 14.72 |
Debt / Equity Ratio | - | - | 0.12 | 0.11 | 0.12 | 0.10 |
Debt / EBITDA Ratio | - | - | 0.52 | 0.49 | 0.69 | 0.62 |
Debt / FCF Ratio | - | - | 0.63 | 0.55 | 1.82 | 1.15 |
Net Debt / Equity Ratio | -0.27 | -0.27 | -0.21 | -0.20 | -0.07 | -0.15 |
Net Debt / EBITDA Ratio | -1.22 | -1.22 | -0.89 | -0.85 | -0.41 | -0.95 |
Net Debt / FCF Ratio | -2.21 | -2.21 | -1.08 | -0.95 | -1.09 | -1.74 |
Asset Turnover | 0.70 | 0.70 | 0.71 | 0.71 | 0.63 | 0.62 |
Inventory Turnover | 2.10 | 2.10 | 2.72 | 2.99 | 2.95 | 2.79 |
Quick Ratio | 1.74 | 1.74 | 1.90 | 2.00 | 1.85 | 1.91 |
Current Ratio | 2.60 | 2.60 | 2.58 | 2.55 | 2.38 | 2.39 |
Return on Equity (ROE) | 12.93% | 12.93% | 12.14% | 8.92% | -4.75% | 8.45% |
Return on Assets (ROA) | 7.18% | 7.18% | 7.14% | 7.61% | 5.01% | 5.20% |
Return on Invested Capital (ROIC) | 17.36% | 17.14% | 15.46% | 18.05% | 12.64% | 10.12% |
Return on Capital Employed (ROCE) | 14.30% | 14.30% | 15.00% | 15.20% | 10.60% | 9.90% |
Earnings Yield | 6.15% | 6.51% | 7.49% | 4.76% | -3.52% | 5.54% |
FCF Yield | 6.03% | 6.38% | 11.21% | 11.33% | 4.68% | 5.85% |
Dividend Yield | 2.23% | 2.13% | 2.60% | 2.25% | 3.03% | 2.88% |
Payout Ratio | 33.83% | 33.83% | 33.40% | 44.59% | - | 44.07% |
Buyback Yield / Dilution | 6.10% | 6.10% | 5.01% | 4.98% | 3.26% | -0.02% |
Total Shareholder Return | 8.33% | 8.22% | 7.61% | 7.22% | 6.29% | 2.86% |